Findings from a new Dartmouth-led study, published in the journal mBio, highlight key differences in the gut microbiome ...

Patients with progressive pulmonary fibrosis who received nerandomilast showed improved forced vital capacity from baseline ...

Aucklander Ben Prince-Saxon is pushing the boundaries of what's possible living with cystic fibrosis.

Adults with progressive pulmonary fibrosis met the primary endpoint of absolute change in FVC with 52-week oral nerandomilast ...